AT253505B - Verfahren zur Herstellung der neuen α-Amino-3-hydroxy-5-isoxazolessigsäure - Google Patents

Verfahren zur Herstellung der neuen α-Amino-3-hydroxy-5-isoxazolessigsäure

Info

Publication number
AT253505B
AT253505B AT41066A AT41066A AT253505B AT 253505 B AT253505 B AT 253505B AT 41066 A AT41066 A AT 41066A AT 41066 A AT41066 A AT 41066A AT 253505 B AT253505 B AT 253505B
Authority
AT
Austria
Prior art keywords
hydroxy
amino
preparation
new
acetic acid
Prior art date
Application number
AT41066A
Other languages
English (en)
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Application granted granted Critical
Publication of AT253505B publication Critical patent/AT253505B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT41066A 1965-04-15 1965-05-17 Verfahren zur Herstellung der neuen α-Amino-3-hydroxy-5-isoxazolessigsäure AT253505B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH530965A CH454147A (de) 1965-04-15 1965-04-15 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
AT253505B true AT253505B (de) 1967-04-10

Family

ID=4291422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT41066A AT253505B (de) 1965-04-15 1965-05-17 Verfahren zur Herstellung der neuen α-Amino-3-hydroxy-5-isoxazolessigsäure

Country Status (3)

Country Link
AT (1) AT253505B (de)
CH (1) CH454147A (de)
DK (1) DK111488B (de)

Also Published As

Publication number Publication date
DK111488B (da) 1968-09-02
CH454147A (de) 1968-04-15

Similar Documents

Publication Publication Date Title
AT280996B (de) Verfahren zur Herstellung von neuen 1-Hydroxyphenyl-2-aminoalkanolen
CH484049A (de) Verfahren zur Herstellung von neuen Hydroxycyclohexylaminen
AT272343B (de) Verfahren zur Herstellung von neuen 2-Cycloalkylamino-oxazolinen
AT271455B (de) Verfahren zur Herstellung von neuen substituierten Phenylaminophenylessigsäureestern
CH451945A (de) Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren
CH446303A (de) Verfahren zur Herstellung von neuen Iminokohlensäureesterderivaten
CH473770A (de) Verfahren zur Herstellung von neuen substituierten Phenylacetamiden
AT277988B (de) Verfahren zur Herstellung von neuen Derivaten der α-Fluormalonsäure
AT270676B (de) Verfahren zur Herstellung von neuen Polycarbonsäure-Additionsprodukten
AT272369B (de) Verfahren zur Herstellung von neuen 6-Amino-uracil-5-carbonamid-N-sulfonamiden
CH503048A (de) Verfahren zur Herstellung von neuen 1-Acyl-3-indolyl-carbonsäurederivaten
CH482727A (de) Verfahren zur Herstellung von neuen Phosphinylimiden
AT277996B (de) Verfahren zur Herstellung von neuen 1-Acyl-3-indolylcarbonsäureverbindungen
CH497411A (de) Verfahren zur Herstellung von neuen Homogonan-Derivaten
AT268525B (de) Verfahren zur Herstellung von neuen Derivaten der 7 Phenylacetamidocephalosporansäure
AT253505B (de) Verfahren zur Herstellung der neuen α-Amino-3-hydroxy-5-isoxazolessigsäure
AT264712B (de) Verfahren zur Herstellung von neuen Derivaten der 6-Aminopenicillansäure
AT277186B (de) Verfahren zur Herstellung von neuen Trihalogenäthylglycinaten
CH531513A (de) Verfahren zur Herstellung von neuen 2-Indolylessigsäurederivaten
AT271417B (de) Verfahren zur Herstellung der neuen 7-Chlor-4-Thiaönanthsäure
AT246338B (de) Verfahren zur Herstellung von neuen Derivaten der Primulasäure
AT266141B (de) Verfahren zur Herstellung von neuen Haxahydropyrimidinderivaten
CH509972A (de) Verfahren zur Herstellung von neuen Diisoeugenol-Derivaten
CH464929A (de) Verfahren zur Herstellung von neuen Penicillansäure-Derivaten
AT252905B (de) Verfahren zur Herstellung von neuen 4-Halogen-5-alkoxysulfamyl-anthranilsäuren